1. Home
  2. »
  3. Tapen ER-50 – Tapentadol Extended Release Tablets 50 mg

Tapen ER-50 – Tapentadol Extended Release Tablets 50 mg

Tapen ER-50 contains Tapentadol, an extended-release opioid analgesic designed to provide effective, long-lasting relief from moderate to severe chronic pain. Its dual mechanism of action combines opioid receptor agonism with norepinephrine reuptake inhibition, offering improved pain control with potentially fewer side effects.

Strength:

  • 50 mg extended-release tablets

Therapeutic Indications:

  • Management of chronic pain conditions requiring continuous, long-term opioid treatment

  • Neuropathic pain

  • Musculoskeletal pain

Mechanism of Action:
Tapentadol works by activating mu-opioid receptors and inhibiting norepinephrine reuptake, resulting in potent analgesia.

Key Features:

  • Extended-release formulation ensures steady, prolonged pain relief

  • Manufactured under GMP-certified conditions

  • Designed for once or twice daily dosing for convenience

  • Improved gastrointestinal tolerability compared to traditional opioids

  • Available in easy-to-swallow tablet form

Packaging:

  • Blister packs containing 50 mg tablets

Storage:
Store below 25°C. Protect from moisture and light.

Note: Prescription-only medicine. Use under strict medical supervision to avoid misuse or dependence.

Epikaas (Epirubicin Hydrochloride) is an anthracycline cytotoxic agent used in the treatment of various cancers. It works by interfering with DNA replication in cancer cells, leading to their destruction.

Strengths Available:

  • Epikaas 10 mg

  • Epikaas 50 mg

Therapeutic Use:

  • Breast Cancer

  • Ovarian Cancer

  • Lung Cancer

  • Gastric Cancer

  • Bladder Cancer (intravesical use)

Mechanism of Action:
Epirubicin intercalates into DNA strands, inhibiting topoisomerase II and generating free radicals, thereby inducing apoptosis in rapidly dividing cancer cells.

Key Features:

  • Manufactured in GMP-certified facilities

  • High purity and stability

  • Supplied in single-dose vial

  • Suitable for intravenous or intravesical administration

  • Stringent quality control for safety and efficacy

Packaging:

  • Sterile, lyophilized powder in glass vial

  • To be reconstituted before use under medical supervision

Storage:
Store between 2°C and 8°C. Protect from light. Do not freeze.

Note: For hospital use only. To be administered by qualified healthcare professionals.